NeuMoDx Molecular Systems
https://www.neumodx.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From NeuMoDx Molecular Systems
Roche Launches COVID-19 Test For Cobas System; BioMérieux Plans Three COVID-19 Tests
Roche announced that the US FDA has granted an Emergency Use Authorization for the cobas SARS-CoV-2 test for patients suspected to have COVID-19. bioMérieux is planning three COVID-19 tests.
Qiagen Secures US HHS Funding For New COVID-19 Test
Qiagen has secured funding from a US government agency to develop a new test kit for COVID-19.
Mayo Clinic Launches COVID-19 Test; Results Within 24 Hours
Mayo Clinic is developing a test to detect COVID-19 in the US.
NeuMoDx Molecular Launches Coronavirus Test
NeuMoDx Molecular announced plans to develop a coronavirus test for its own high-throughput molecular diagnostics platform.
Company Information
- Industry
- Biotechnology
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NeuMoDx Molecular Systems
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice